These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 36344361)

  • 1. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.).
    Griffin I; Berry I; Navarra T; Priyamvada L; Carson WC; Noiman A; Jackson DA; Waltenburg MA; Still W; Lujan L; Beverley J; Willut C; Lee M; Mangla A; Shelus V; Hutson CL; Townsend MB; Satheshkumar PS;
    Vaccine; 2024 Jul; 42(19):4056-4065. PubMed ID: 38762357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.
    Zaeck LM; Lamers MM; Verstrepen BE; Bestebroer TM; van Royen ME; Götz H; Shamier MC; van Leeuwen LPM; Schmitz KS; Alblas K; van Efferen S; Bogers S; Scherbeijn S; Rimmelzwaan GF; van Gorp ECM; Koopmans MPG; Haagmans BL; GeurtsvanKessel CH; de Vries RD
    Nat Med; 2023 Jan; 29(1):270-278. PubMed ID: 36257333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
    Payne AB; Ray LC; Kugeler KJ; Fothergill A; White EB; Canning M; Farrar JL; Feldstein LR; Gundlapalli AV; Houck K; Kriss JL; Lewis NM; Sims E; Smith DK; Spicknall IH; Nakazawa Y; Damon IK; Cohn AC; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1278-1282. PubMed ID: 36201401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022.
    Kriss JL; Boersma PM; Martin E; Reed K; Adjemian J; Smith N; Carter RJ; Tan KR; Srinivasan A; McGarvey S; McGehee J; Henderson D; Aleshire N; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1374-1378. PubMed ID: 36301741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the acute antibody response of monkeypox and MVA-BN vaccine following an Australian outbreak.
    Asquith W; Hueston L; Dwyer D; Kok J; Ko D; Fennel M; Rockett R; Rai NJ; Li Y; Sriramoju S; Sutor A; O'Sullivan M
    J Med Virol; 2024 Jan; 96(1):e29407. PubMed ID: 38240403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Rao AK; Petersen BW; Whitehill F; Razeq JH; Isaacs SN; Merchlinsky MJ; Campos-Outcalt D; Morgan RL; Damon I; Sánchez PJ; Bell BP
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(22):734-742. PubMed ID: 35653347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.
    van Leeuwen LP; Shamier MC; Verstrepen BE; Götz HM; Schmitz KS; Akhiyate N; Wijnans K; Bogers S; van Royen ME; van Gorp EC; Koopmans MP; de Vries RD; GeurtsvanKessel CH; Zaeck LM
    Euro Surveill; 2024 Sep; 29(38):. PubMed ID: 39301741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status of Vaccine Development for Monkeypox Virus.
    Rastogi A; Kumar M
    Adv Exp Med Biol; 2024; 1451():289-300. PubMed ID: 38801585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects.
    Sammartino JC; Cassaniti I; Ferrari A; Piralla A; Bergami F; Arena FA; Paolucci S; Rovida F; Lilleri D; Percivalle E; Baldanti F
    J Med Virol; 2023 May; 95(5):e28778. PubMed ID: 37212258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
    Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
    Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
    Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinating against monkeypox in the Democratic Republic of the Congo.
    Petersen BW; Kabamba J; McCollum AM; Lushima RS; Wemakoy EO; Muyembe Tamfum JJ; Nguete B; Hughes CM; Monroe BP; Reynolds MG
    Antiviral Res; 2019 Feb; 162():171-177. PubMed ID: 30445121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.
    Ilchmann H; Samy N; Reichhardt D; Schmidt D; Powell JD; Meyer TPH; Silbernagl G; Nichols R; Weidenthaler H; De Moerlooze L; Chen L; Chaplin P
    J Infect Dis; 2023 May; 227(10):1203-1213. PubMed ID: 36408618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
    Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
    BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus.
    Gushchin VA; Ogarkova DA; Dolzhikova IV; Zubkova OV; Grigoriev IV; Pochtovyi AA; Iliukhina AA; Ozharovskaia TA; Kuznetsova NA; Kustova DD; Shelkov AY; Zrelkin DI; Odintsova AS; Grousova DM; Kan VY; Davtyan SA; Siniavin AE; Belyaeva ED; Botikov AG; Bessonova AA; Vasilchenko LA; Vasina DV; Kleymenov DA; Slutskiy EA; Tkachuk AP; Burgasova OA; Loginova SY; Rozhdestvensky EV; Shcheblyakov DV; Tsibin AN; Komarov AG; Zlobin VI; Borisevich SV; Naroditsky BS; Logunov DY; Gintsburg AL
    Front Immunol; 2022; 13():1023164. PubMed ID: 36466896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
    Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
    Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention.
    Kandeel M; Morsy MA; Abd El-Lateef HM; Marzok M; El-Beltagi HS; Al Khodair KM; Albokhadaim I; Venugopala KN
    Int Immunopharmacol; 2023 Jun; 119():110206. PubMed ID: 37087871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV-1 from Guangzhou, China.
    Dai J; Li F; Yang Y; Tang X; Li L; Yu H
    J Med Virol; 2023 May; 95(5):e28763. PubMed ID: 37212313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.